Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program
FDA’s Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER) initiated the Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program to help further accelerate the development of …